Fed. Circ. Backs AstraZeneca Win In Seroquel XR Patent Row
The Federal Circuit on Thursday affirmed a lower court's ruling that AstraZeneca PLC's patent for the anti-psychotic drug Seroquel XR was infringed by four generics makers....To view the full article, register now.
Already a subscriber? Click here to view full article